Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection

Dig Dis Sci. 2004 Nov-Dec;49(11-12):1966-70. doi: 10.1007/s10620-004-9602-3.

Authors

Valentin Fuhrmann¹, Ludwig Kramer, Edith Bauer, Hermann Laferl, Gerhard Tucek, Gerhard Dekan, Peter Schenk

Affiliation

¹ Department of Internal Medicine 4, General Hospital and University of Vienna, Vienna, Austria.

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / adverse effects*
Antiviral Agents / therapeutic use
Fatal Outcome
Hepatitis C / drug therapy*
Humans
Interferon alpha-2
Interferon-alpha / adverse effects*
Interferon-alpha / therapeutic use
Lung Diseases, Interstitial / chemically induced*
Lung Diseases, Interstitial / drug therapy
Male
Middle Aged
Polyethylene Glycols
Recombinant Proteins
Ribavirin / adverse effects*
Ribavirin / therapeutic use

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
Ribavirin
peginterferon alfa-2b